Genetics of stress response and stress-related disorders by Ising, Marcus & Holsboer, Florian
ecent advances in molecular genetics have stim-
ulated basic and clinical research,and opened up access to
hypothesis-driven and unbiased genetic approaches.With
knowledge of the genes involved in complex basic func-
tions like the stress response,and of multifactorial diseases
like stress-related disorders,we can improve our under-
standing of the mechanisms and moderators involved in
the biology of normal and altered stress response,which
in turn will help to identify new drug targets and inter-
ventions for stress-related disorders.
Stress response and stress-related disorders
Though there is no generally accepted definition,stress
is usually defined as a state of disturbed homeostasis
evoking a multiplicity of somatic and mental adaptive
reactions,which are summarized as stress response aim-
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The major findings regarding the genetics of stress response and stress-related disorders are: (i) variations in genes
involved in the sympathetic system or in the hypothalamic-pituitary-adrenocortical axis are associated with altered
stress responses; (ii) genes related to the renin-angiotensin-aldosterone system or inflammation/immune response
show associations with cardiovascular disorders; (iii) genes involved in monoaminergic neurotransmitter systems are
associated with bipolar disorder and unipolar depression. The vast majority of these association studies followed a
conventional hypothesis-driven approach, restricting the gene selection to established candidates. This very con-
servative approach retarded our understanding of the complex interplay between genetic factors, stress response,
and stress-related disorders. Chip-based whole-genome technologies will open up access to new unbiased and sta-
tistically efficient approaches that will help to identify new candidate genes, which should be thoroughly validated
in clinical and preclinical confirmatory studies. This, together with the use of new text- and information-mining tools,
will bring us closer to integrating all the findings into sophisticated models delineating the pathways from genes to
stress response and stress-related disorders.
© 2006, LLS SAS Dialogues Clin Neurosci. 2006;8:433-444.ing to reconstitute the initial homeostasis or allostasis,
1
ie,a new level of homeostasis after successful adaptation.
2
The pioneer of stress research, Hans Selye, claimed a
stimulus-independent nonspecificity of the stress
response
3,4 which has been criticized by others.
1,5,6
Nevertheless, different kinds of stressors, physical and
psychosocial,lead equivocally to a rapid activation of the
sympathetic nervous system followed by a stimulation of
the hypothalamic-pituitary-adrenocortical (HPA) axis.
Successful coping with stress implies an appropriate reg-
ulation of the stress response and an effective termina-
tion when the stress is over or the individual has adapted
to the new conditions.
The perception of a stressful situation activates a large
number of neuronal circuits in the prefrontal cortex and
limbic system, including the hypothalamus, where the
sympathetic nervous system is activated;this in turn leads
to a widespread release of noradrenalin from the post-
ganglionic fibers and to the release of adrenalin (and
noradrenalin) from the adrenal medulla.Additionally,
the parvocellular neurons of the hypothalamus are stim-
ulated to secrete the neuropeptides corticotropin-releas-
ing hormone (CRH) and vasopressin (AVP) into the por-
tal vessel system to activate the synthesis and release of
corticotropin (ACTH) from the anterior pituitary.
ACTH,in turn,stimulates the adrenal cortex to synthe-
size and release glucocorticoids,in particular cortisol (in
humans).These hormones have a multiplicity of func-
tions, which are necessary for the adaptation to acute
stress,but can be pathogenic when the organism is per-
sistently exposed.Therefore,a fine-tuned regulation of
the sympathetic system and of the HPA axis is essential
to avoid the development of a pathological dysregulation
that can progress to stress-related disorders,which can
be defined as illnesses whose causation,onset,or devel-
opment is substantially influenced by stress and its neu-
robiological correlates.Among others,cardiovascular dis-
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Selected abbreviations and acronyms
ACTH adrenocorticotropic hormone,corticotropin
AVP (arginin)-vasopressin
CRH corticotropin-releasing hormone
DEX dexamethasone
GR glucocorticoid receptor
HPA hypothalamic-pituitary-adrenocortical
MR mineral corticoid receptor
RAAS renin-angiotensin-aldosterone system
TSST Trier Social Stress Test
Figure 1. Model for normal and impaired regulation of the HPA axis. HPA, hypothalamic-pituitary-adrenocortical; CRH, corticotropin-releasing hor-
mone; AVP, arginin-vasopressin; POMC, pro-opiomelanocortin; ACTH, adrenocorticotropic hormone
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Cortisolorders such as hypertension and coronary artery disease,
as well as psychiatric diseases such as bipolar disorder
and unipolar depression,are examples of stress-related
disorders that will be discussed in this review.
The main central structure for the regulation of the auto-
nomic nervous system is the hypothalamus, which
receives input from cortical and subcortical structures,as
well as from peripheral receptors and organs.The pri-
mary regulatory elements of the HPA axis are the corti-
costeroid receptors,glucocorticoid receptors (GR),and
mineral corticoid receptors
7 (for details see ref 8).
As indicated in the left panel of Figure 1,activation of the
HPA axis leads to the secretion of cortisol (in humans),
which induces a negative feedback inhibition to CRH
and AVP (at the level of the hypothalamus) and to
ACTH (at the level of the anterior pituitary).Impaired
corticosteroid signaling results in an attenuation of the
negative feedback inhibition,which could result in the
failure to sufficiently suppress CRH and AVP release
from the hypothalamus and ACTH from the anterior
pituitary,which in turn leads to chronically elevated lev-
els of cortisol (Figure 1,right panel).The attenuated neg-
ative feedback inhibition can be most sensitively diag-
nosed with a neuroendocrine challenge test of the HPA
axis,the combined dexamethasone (dex)/CRH test.
9 In
this test, the stimulating effects of 100 µg intravenous
human CRH upon ACTH and cortisol are examined
under the suppressive action of 1.5 mg of dexametha-
sone.
10,11This test is sensitive to impaired GR signaling at
the pituitary level,as well as to the effects of increased
secretion of the hypothalamic neuropeptides CRH and
AVP,which is a consequence of impaired central GR sig-
naling.
8,12,13
Impaired HPA axis regulation during an acute episode is
the most consistent laboratory finding in depression and
bipolar disorder (see refs 13 to 15 for reviews),which cor-
responds to the concept of stress-related disorders.
Accordingly,the majority of depressed patients exhibit
an exaggerated ACTH and cortisol response to the com-
bined dex/CRH test (Figure 2).
These alterations were shown to normalize after suc-
cessful antidepressant treatment,
11,16-18 suggesting that
altered HPA axis regulation and its normalization is
involved in the pathogenesis of and recovery from
depression,respectively.
Genetics of stress response
Evidence for heritability is a prerequisite for the involve-
ment of genetic factors.The most efficient way for eval-
uating heritability is twin studies comparing phenotypi-
cal similarity between monozygotic and dizygotic twins.
Twin data are available for the Trier Social Stress Test
(TSST),
19 which is a standardized procedure for the
assessment of the psychosocial stress response.Briefly,
this test comprises a public speaking task involving a
mock job interview and a mental arithmetic task.
Subjects are asked to prepare a presentation for pro-
moting their candidacy for a position that is tailored to
their education.After the preparation time,subjects give
their presentation in front of a panel of judges who are
evaluating the talk. After 5 minutes, subjects are
requested to perform an unexpected mental arithmetic
task for a further 5 minutes.HPA axis activity (plasma
ACTH and cortisol and/or salivary cortisol) is evaluated
before and after the tasks as well as during recovery.
Federenko and coworkers
20 reported a heritability esti-
mate (h
2) of 0.32 for the plasma cortisol response to the
TSST in 33 monozygotic and 25 dizygotic twin pairs,sug-
gesting moderate heritability,but this increased up to 0.98
in two repetitions of the test.Heritability estimates for
ACTH and salivary cortisol were distinctly smaller in the
first test session,but increased markedly in the repeated
test sessions. A previous study by Kirschbaum and
coworkers
21 with 13 monozygotic and 11 dizygotic twin
pairs also reported only marginal heritability for the sali-
vary cortisol response to a single administration of the
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Figure 2. Cortisol response to the combined dex/CRH test is elevated
in depression (AUC, P<.001) suggesting dysregulation of the
HPA axis due to impaired glucocorticoid signaling. Dex, dex-
amethasone; CRH, corticotropin-releasing hormone; HPA,
hypothalamic-pituitary-adrenocortical; AUC, area under the
curve
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No heritability data are available for the combined
dex/CRH test. However, in the Munich Vulnerability
Study,
22,23 the combined dex/CRH test was conducted in
healthy first-degree relatives of patients with a major
depressive disorder,who are assumed to carry a genetic
vulnerability for affective disorders. These so-called
high-risk probands (HRPs) are characterized by a mod-
erately elevated hormonal response to the combined
dex/CRH test,which was significantly higher compared
with controls without a personal or familial history of
psychiatric disorders, but less pronounced compared
with the response in acutely depressed patients.Modell
and coworkers
24 replicated these findings in still unaf-
fected HRPs who were re-examined in a follow-up
investigation about 4 years later (Figure 3), suggesting
that this trait-like impaired regulation of the HPA sys-
tem could reflect the genetic vulnerability for affective
disorders in these subjects.
Despite the statistical evidence for a considerable heri-
tability of the stress response,the number of significant
genetic findings is small, and the conclusiveness rather
limited.The findings are summarized in Table I.Due to
the importance of the HPA system for the stress
response, which is primarily regulated by GR, the GR
gene has been proposed as the primary candidate for the
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Figure 3. Cortisol response to the combined dex/CRH test is moderately
elevated in high risk probands for affective disorders (AUC,
P<.05), which was stable over time at the group level (AUC,
P=.758) as well as at the individual level (Pearson correlation,
r=.51, P<.05) in a follow-up investigation 4 years later. Dex,
dexamethasone; CRH, corticotropin-releasing hormone; AUC,
area under the curve
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Table I. Genetic associations with stress response in human paradigms. GABA, γ-aminobutyric acid; ACTH, adrenocorticotropic hormone; CRH, cor-
ticotropin-releasing hormone; HPA, hypothalamic-pituitary-adrenal
Genes Chromosomal  Results
position
Psychosocial stress response
Glucocorticoid receptor (GR, NR3C1) 5q31.3 Combined BclI and N363S polymorphisms associated with salivary cortisol
response to psychosocial stress (Trier Social Stress Test, TSST) in male mono- and
dizygotic twins
25; replicated in male unrelated subjects but not in female subjects
(Kumsta and Wüst, 2006; personal communication)
GABA(A) α6 receptor subunit (GABRA6) 5q34 T1521C polymorphism associated with ACTH, cortisol, and blood pressure
response to psychosocial stress (TSST) in healthy subject
26
Opioid receptor µ1 (OPRM1) 6q24-q25 A118G polymorphism associated with cortisol response to psychosocial stress
(modified TSST) in healthy subjects
27
Endocrine HPA challenge tests
Glucocorticoid receptor (GR, NR3C1) 5q31.3 BclI and N363S polymorphisms associated with ACTH and cortisol suppression
after oral low-dose dexamethasone (dexamethasone suppression test) in elderly
subjects
28,29
Angiotensin-converting enzyme (ACE) 17q23.3 Insertion/deletion polymorphism associated with hormonal response to the com-
bined dexamethasone suppression/CRH stimulation test in acute major depres-
sion
30,31
Brain-derived neurotrophic factor (BDNF) 11p13 Val66Met polymorphism associated with ACTH and cortisol response to the com-
bined dexamethasone suppression/CRH stimulation test in acute depression
23genetic association studies. Significant associations
between GR and psychosocial stress response were
reported, but only when a haplotype approach is
applied
25 or when male subjects are separately analyzed
(Kumsta and Wust, 2006; personal communication).
Further genetic associations, not yet replicated, are
reported for the γ-aminobutyric acid (GABA) A 6
receptor subunit gene
26 and for an nonsynonymous exon
single-nucleotide polymorphism (SNP) of the micro-opi-
oid receptor 1 (MOR) gene.
27
Additional evidence for an involvement of the GR gene
in the genetics of the stress response has been provided
by two other studies (Table I) employing a low-dose dex
suppression test in elderly subjects.
28,29 In this test,
plasma cortisol levels after oral administration of dex
are interpreted as an indicator for GR sensitivity,which
is the major regulator of the stress hormone activity at
the pituitary level.Two other studies in patients suffer-
ing from major depression
30,31 reported associations
between the angiotensin-converting enzyme (ACE)
gene and the hormonal response to the combined dex
suppression/CRH stimulation test, which is the most
sensitive challenge test for evaluating stress hormone
regulation. ACE is involved in the so-called renin-
angiotensin cascade of water regulation, which in turn
affects blood volume and blood pressure. A recent
study observed an association between the combined
dex/CRH test and brain-derived neurotrophic factor
(BDNF) in depressed patients, which has been inter-
preted as evidence for an involvement of a reduced
neuroplasticity in the development of disturbed HPA
axis regulation.
23
Taken together,there are only a limited number of stud-
ies examining the association between candidate genes
and the stress response. Besides genes involved in the
sympathetic (ACE) or HPA axis-mediated (GR) stress
response,further genes constituting different biological
systems implicated in emotional regulation
26 and neuro-
plasticity (BDNF) have been examined. However, the
results show only moderate effect sizes, although heri-
tability estimates suggest a strong involvement of genetic
factors. Further evidence for genes involved in the reg-
ulation of the stress response could be provided by clin-
ical studies investigating genetic vulnerability factors for
stress-related disorders.These genetic risk factors are
assumed to be responsible for an inappropriate response
to repeated and/or continuous stress and thus for medi-
ating the vulnerability for stress-related disorders.
Genetics of stress-related disorders
A large number of diseases can be understood as stress-
related disorders,and most of them are characterized by
an at least moderate heritability.In this review,we focus
on the most prevalent stress-related disorders,hyperten-
sion and coronary artery disease,as examples of cardio-
vascular disorders,and on bipolar disorder and unipolar
depression as examples of psychiatric disorders.
Cardiovascular disorders are the leading cause of mor-
tality in the Western world,and are projected to become
the leading cause of disease burden worldwide in 2020.
32
Essential hypertension is the most common cardiovas-
cular disorder,with a lifetime prevalence of above 50%
in most western communities,affecting approximately 1
billion individuals worldwide
33; heritability estimates
around 30% have been reported.
34 Myocardial infarction
is a serious outcome of coronary artery disease. Twin
studies suggest that the risk for myocardial infarction is
fairly heritable, with a heredity estimate of 60% in
females and 26% in males.
35
A large number of case-control association studies in
essential hypertension are available (Table IIa) focussing
on a number of candidate gene systems.The majority of
findings have been obtained with candidates from the
sympathetic system,including adrenergic genes,genes of
the renin-angiotensin-aldosterone system (RAAS),and
genes involved in vascular regulation.Despite the large
number of studies, only a few associations can be
regarded as convincing,including the associations with
the angiotensinogen (AGT), aldosterone synthase
(CYP11B2),and with the renin (REN) gene,all involved
in the RAAS.
Several studies report gene x gene interaction effects,eg,
between the endothelin 1 (EDN1) and serotonin recep-
tor 2a (5HTR2A) genes,
69 and between the ACE,aldos-
terone synthase (CYP11B2), and α adductin (ADD1)
genes.
42 Several candidate genes from other biological
systems (eg, DRD2, GNB3, ACSM3) have been pro-
posed,but no unambiguous conclusion can yet be drawn
from the findings from these studies.
As for hypertension,a large number of genetic associa-
tion studies have also been conducted for coronary artery
disease.However,the results are more difficult to inter-
pret than in hypertension,since different clinical condi-
tions,including myocardial infarction and arteriosclero-
sis/stenosis, are integrated as coronary artery disease.
Most candidate genes showing replicable associations
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437have been derived from the concept of inflammation as
a major risk factor for coronary heart disease.Convincing
evidence for genetic associations has been reported for
genes involved in innate immunity or genes moderating
the inflammatory reaction,such as leukotrienes and lym-
photoxins (Table IIb).
The number of positive results outweighs the negative
findings,and most effect sizes were in an at least moder-
ate range.Nevertheless,not all candidate genes derived
from potent endophenotypes show convincing associa-
tions.One example of this divergence is lipoprotein A,
which has been identified as a potent vulnerability factor
for coronary artery disease,
98 even though there is only a
little evidence for a genetic association of the lipoprotein
A (LPA)  gene. Further gene candidates have been
derived from studies in mendelian disorders involving
premature coronary artery diseases such as familial
hypercholesterolemia,familial defective apolipoprotein
B (APOB), sitosterolemia, and Tangier disease. An
overview of these findings is provided by Watkins and
Farrall.
99 However, the translation of these findings to
multifactorial cardiovascular disorders is limited.
Besides cardiovascular diseases, bipolar disorder and
unipolar depression are further examples of burdensome
stress-related disorders with a distinct heritability and a
high prevalence in the general population, especially
unipolar depression, which is projected to become the
second leading cause for disease burden in 2020.
32
Lifetime prevalence of bipolar disorder is around 1%
according to population-based epidemiological studies in
Europe
100 as well as in the US,
101 while lifetime prevalence
of unipolar depression is distinctly higher,with a similar
rate of 17% in Europe and in the USA.Twin studies sug-
gest a high heritability for bipolar disorder, with heri-
tability estimates,h
2,ranging between 80% and 90%,and
a moderate heritability for unipolar depression with h
2
between 33% and 42%.
102
Most candidate genes for association studies with bipo-
lar disorder and unipolar depression have been derived
from neurotransmitter systems involved in antidepres-
Clinical research
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Table IIa. Replicated findings of genetic associations with hypertension. 5-HT, serotonin; SAH, SA hypertension-associated homolog
Genes Chromosomal  Results
position
Adrenergic system
β2-adrenoceptor (ADRB2) 5q31-q32 Significant associations reported in Caucasian
36,37 and Asian populations,
38
but also several negative findings
39
β3-adrenoceptor (ADRB3) 8p12-p11.2 Significant associations reported in Caucasian population
40 and in male 
type 2 diabetics
41
Renin-angiotensin-aldosterone system
Angiotensin-converting enzyme (ACE) 17q23.3 Significant small to moderate effects,
42-45 but also several negative 
reports
40,46-48
Angiotensinogen (AGT) 1q42-q43 Largest number of positive studies,
47,49,50 but also some negative findings
51
Aldosterone synthase (CYP11B2) 8q21-q22 More positive
52-56 than negative
57 reports
Angiotensin (AT1) receptor (AGTR1) 3q21-q25 Mixed results, positive findings
49 as well as negative reports
44
α Adductin (ADD1) 4p16.3 Mixed results, positive findings
58 as well as negative reports
51
Atrial natriuretic peptide (NPPA, NPPB) 1p36.2 Less positive findings
59 than negative reports
60,61
Renin (REN) 1q32 Predominance of positive findings
62-64
11β-hydroxisteroid dehydrogenase 2 (HSD11B2) 16q22 Weak positive effects are reported
65,66
Vascular system
Endothelin 1 (EDN1) 6p24.1 Significant association with blood pressure in obese subjects;
67,68 some
evidence for association with hypertension
69; in interaction with 5-HTR2A
Nitric oxide synthase (NOS3) 7q36 Less positive findings
70 than negative reports
71,72
Other genes
D2 receptor (DRD2) 11q23 Associated with hypertension
73 and with elevated blood pressure in 
personality disorder
74
G protein β3 subunit (GNB3) 12p13 Less positive findings
75 than negative reports
51,54,76
SAH (ACSM3) 16p13.11 Mixed results, positive findings
77 as well as negative reports
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sant drug action.Only some of the findings could be con-
sistently replicated,including associations between the
monoaminoxidase A (MAOA)
103 and catechol-o-methyl-
transferase (COMT) gene and bipolar disorder and tryp-
tophan hydroxilase 2 (TPH2) gene and unipolar depres-
sion (Table III).Further conclusive evidence exists for an
involvement of the D-aminoacidoxidase activator
DAOA (G72)/G30 locus in the susceptibility for bipolar
disorder,but also for schizophrenia.A large number of
studies have examined the genetic associations between
Table IIb. Replicated findings of genetic associations with coronary artery disease.
Genes Chromosomal  Results
position
Innate immunity
CD14 molecule (CD14) 5q31.1 Significant associations with myocardial infarction,
79-81 but also negative 
reports
82,83
Toll-like receptor 4 (TLR4) 9q32-q33 Significant associations reported for acute coronary events
84 and myocardial 
infarction
85,86 but not with coronary stenosis
87
Leukotrienes
Arachidonate 5-lipoxygenase-activating  13q12 Evidence for an association with myocardial infarction
88,89 and
protein (ALOX5AP) arteriosclerosis
90
Leukotriene A4 hydrolase (LTA4H) 12q22 Significant association with ethnicity-specific risk for myocardial infarction in 
different ethnic samples
91
Other genes
Lymphotoxine α (LTA) 6p21.3 Significant association with myocardial infarction in Japanese populations
92,93
as well with arteriosclerosis in Caucasians,
94 but also negative reports
95,96
Galectin 2 (LGALS2) 22q13.1 Associated with myocardial infarction
97; protein interacts with LTA
Table III. Replicated findings of genetic associations with bipolar disorder and unipolar depression. 5-HT, serotonin
Genes Chromosomal  Results
position
Bipolar disorder
Monoaminoxidase A (MAOA) 5q31.3 Significant associations with a modest effect size confirmed by meta-
analyses
103,104 suggesting greatest effects in female patients
Catechol-o-methyltransferase (COMT) 22q11.21 Meta-analysis revealed a modest effect size
105,106 and has been suggested as a 
common susceptibility gene for bipolar disorder and schizophrenia
107
5-HT transporter (SLC6A4) 17q11.1-q12 A number of positive studies
108-111 confirmed in meta-analyses,
112,113 but also 
negative studies for 5-HTTLPR,
114 one negative meta-analysis
105
D-aminoacidoxidase activator DAOA 13q33-q34 Several positive reports with polymorphisms in the proximity of these nested 
(G72) / G30 genes,
7,115-117 but also with schizophrenia, suggesting a common susceptibility 
locus
118
Brain-derived neurotrophic factor (BDNF) 11p13 Family-based association studies showed significant effects
119,120 but most 
replication studies were negative
121-124; one study suggested association with a 
subgroup of patients displaying rapid cycling
124
P2X ligand-gated ion channel 7 (P2RX7) 12q24 Significant associations reported
125,126
Unipolar depression
Tryptophan hydroxilase 2 (TPH2) 12q21.1 Significant associations with major depression
127,128 and suicide
129
5-HT transporter (SLC6A4) 17q11.1-q12 More depressive symptoms in carriers of the short 5-HTTLPR allele,
130,131 but also 
negative reports
114,132
Glucocorticoid receptor (NR3C1) 5q31.3 BclI and ER22/23EK polymorphisms associated with susceptibility to recurrent 
unipolar depression
133
P2X ligand-gated ion channel 7 (P2RX7) 12q24 Significant associations with unipolar depression reported
134,135polymorphisms in the serotonin (5-HT) transporter
(SLC6A4) gene and bipolar disorder and unipolar
depression.Most attention focused on a functional inser-
tion/deletion polymorphism in the promoter region to
SLC6A4,known as 5HTTLPR.Despite several positive
results,the number of negative replications is increasing,
and the relevance of this polymorphism for the suscepti-
bility to bipolar disorder or unipolar depression is mean-
while being challenged.
Besides SLC6A4,P2X ligand-gated ion channel 7
125 is the
only gene showing replicated effects for susceptibility to
both bipolar disorder and unipolar depression.This gene
codes for a cation-selective ion channel expressed in cen-
tral glial cells as well as in neurons,and is assumed to reg-
ulate immune function and neurotransmitter release.
136,137
In summary,genetic association studies in stress-related
disorders have provided evidence for an involvement of
several other genes not identified by basic genetic stud-
ies on stress response.Since an inappropriate response
to repeated and/or continuous stress mediates the sus-
ceptibility to stress-related disorders,these genes are also
assumed to moderate the stress response. We have
reviewed genetic association studies in hypertension,
coronary artery disease,bipolar disorder,and unipolar
depression.Due to the large and rapidly increasing num-
ber of publications,it is impossible to provide a complete
overview.However,we have tried to summarize the most
consistent and most frequently discussed findings.It is
important to note that different classes of candidate
genes have been investigated in the four diagnostic
groups reported in this review, despite their common
relationship to stress and inappropriate stress response.
While candidate genes in hypertension and coronary
artery disease are primarily related to the RAAS and to
inflammation/immune response,respectively,the major-
ity of candidate genes in bipolar disorder and unipolar
depression are derived from monoaminergic neuro-
transmitter systems.This makes it clear that our actual
knowledge of the complex interplay between genetic fac-
tors,altered stress response,and stress-related disorders
is still limited, and that further research and new
approaches are required to improve our understanding
of these complex functions.
Conclusion and outlook
The summarized findings do not provide an exhaustive
and satisfying answer about the genetics of stress
response and stress-related disorders.Many single find-
ings are still unconnected,and the restriction of the gene
selection to established candidates has retarded our
understanding of the complex interplay between genetic
factors, stress response, and stress-related disorders.
Sophisticated models,especially those aiming to integrate
the findings from basic and clinical research as well as
from the different types of stress-related disorders,are
required to close the gap in our knowledge. The new
chip-based whole-genome technologies, Affymetrix
GeneChip and Illumina Genotyping BeadChip,are pow-
erful tools for this endeavor.With this technology, the
advantages of an unbiased approach as provided by link-
age analysis,and the statistical power of association stud-
ies are combined to identify new candidate genes.How-
ever, results from unbiased approaches are always
preliminary,and require validation in confirmatory stud-
ies.This means that independent replication studies are
needed,but also clinical studies taking gene x gene and
gene x environment interactions into account.For causal
inferences,preclinical experiments are required,includ-
ing (conditional) genetic modification and the develop-
ment of specific compounds as research tools for the pro-
tein targets.Finally,text- and information-mining tools,
which are already available but have to be further devel-
oped, will be very helpful to integrate all findings into
sophisticated models delineating the pathways from
genes to stress response and stress-related disorders.
There is still a long way to go—but the prerequisites for
success are more present than ever. ❏
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Genetica de la respuesta al estrés y de los
trastornos relacionados con el estrés
Los descubrimentos principales en la genética de y
de los trastornos relacionados con el estrés son: i)
las variaciones de los genes implicados en el sistema
simpático o en el eje hipotálamo-hipófisis-corteza
suprarrenal están asociadas con respuestas altera-
das al estrés; ii) los genes relacionados con el sis-
tema renina-angiotensina-aldosterona o la res-
puesta inflamatoria/inmunitaria están asociados a
los trastornos cardiovasculares; iii) los genes impli-
cados en los sistemas neurotransmisores monoami-
nérgicos están asociados al trastorno bipolar y a la
depresión unipolar. La inmensa mayoría de estos
estudios de asociación siguieron un enfoque con-
vencional, impulsado por hipótesis, lo que restringe
la selección de genes candidatos conocidos. Este
método tan conservador ha retrasado el conoci-
miento de la interrelación compleja entre los fac-
tores genéticos, la respuesta al estrés y los trastor-
nos relacionados con éste. Las tecnologías de chip
para el estudio de todo el genoma abrirán las puer-
tas a métodos nuevos, objectivos y eficaces, lo que
estadísticamente permitirá identificar nuevos genes
candidatos que serán validados minuciosamente en
estudios confirmatorios clínicos y preclínicos. Todo
ello, sumado al uso de nuevos instrumentos para la
explotación de texto e información, nos ayudará a
integrar todos los datos dentro de modelos com-
plejos que delimiten las vías desde los genes hasta
la respuesta al estrés y los trastornos relacionados
con el estrés.
Génétique de la réponse au stress et des
troubles liés au stress
Voici les principaux résultats sur la génétique de la
réponse au stress et des troubles liés au stress: 1)
les variations des gènes impliqués dans le système
sympathique ou l’axe hypothalamo-hypophyso-sur-
rénalien sont associées à des anomalies de la
réponse au stress ; 2) les gènes liés au système
rénine-angiotensine-aldostérone ou à une la
réponse inflammatoire/immune sont associés avec
des maladies cardiovasculaires ; 3) les gènes impli-
qués dans les systèmes de neurotransmission
monoaminergiques sont associés aux troubles
bipolaires et à la dépression unipolaire. La grande
majorité de ces études d’association a suivi une
approche conventionnelle hypothético-déductive,
limitant donc la sélection des gènes aux candidats
établis. Cette approche très conservatrice a retardé
notre compréhension des interactions complexes
entre les facteurs génétiques, la réponse au stress
et les troubles liés au stress. Les technologies de
puce à ADN sur le génome entier ouvriront la voie
à de nouvelles approches non biaisées et statisti-
quement efficaces qui permettront d’identifier de
nouveaux gènes candidats. Ces derniers devront
être minutieusement validés dans des études cli-
niques et précliniques de confirmation. Ces tech-
nologies, associées à de nouveaux outils d’analyse
des textes et des informations, nous permettront
d’intégrer plus facilement tous les résultats dans
des modèles sophistiqués précisant les voies qui
vont des gènes à la réponse au stress et aux
troubles liés au stress.Clinical research
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